Contact Us
Drug Search Results
More Filters [+]

Telavancin

Alternative Names: telavancin, vibativ
Latest Update: 2024-12-09
Latest Update Note: News Article

Product Description

Telavancin (Vibativ(®)), a lipoglycopeptide antibacterial agent, exhibits potent in vitro activity against Gram-positive bacteria associated with nosocomial pneumonia infections, including meticillin/oxacillin-resistant Staphylococcus aureus (MRSA) isolates and S. aureus isolates with reduced susceptibility to vancomycin. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/24190596/)

Mechanisms of Action: Cell Wall Inhibitor

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | European Medicines Agency | Germany | Greece | Hungary | Ireland | Israel | Italy | Jordan | Lithuania | Portugal | Russia | Saudi Arabia | Spain | Sweden | United Kingdom | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Telavancin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

12/09/2024

News Article

 FDA APPROVES ACETADOTE® sNDA

11/19/2024

News Article

 Kevin Krause named President and CEO of ArrePath

11/06/2024

News Article

 CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

11/05/2024

News Article

 New Study Compares Caldolor® (ibuprofen injection) to ketorolac

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions